z-logo
open-access-imgOpen Access
Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin
Author(s) -
Wenhao Yu,
Ana Katherine Gonçalves,
Shuping Li,
Hiroko Kishikawa,
Guangjie Sun,
Hailing Yang,
Nil Vanli,
Yunxia Wu,
Yuxiang Jiang,
Miaofen G. Hu,
Roland H. Friedel,
Guofu Hu
Publication year - 2017
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2017.10.005
Subject(s) - biology , angiogenin , plexin , thrombospondin , semaphorin , microbiology and biotechnology , evolutionary biology , angiogenesis , computational biology , genetics , receptor , metalloproteinase , matrix metalloproteinase
Angiogenin (ANG) is a secreted ribonuclease (RNase) with cell-type- and context-specific roles in growth, survival, and regeneration. Although these functions require receptor-mediated endocytosis and appropriate subcellular localization, the identity of the cell surface receptor remains undefined. Here, we show that plexin-B2 (PLXNB2) is the functional receptor for ANG in endothelial, cancer, neuronal, and normal hematopoietic and leukemic stem and progenitor cells. Mechanistically, PLXNB2 mediates intracellular RNA processing that contribute to cell growth, survival, and regenerative capabilities of ANG. Antibodies generated against the ANG-binding site on PLXNB2 restricts ANG activity in vitro and in vivo, resulting in inhibition of established xenograft tumors, ANG-induced neurogenesis and neuroprotection, levels of pro-self-renewal transcripts in hematopoietic and patient-derived leukemic stem and progenitor cells, and reduced progression of leukemia in vivo. PLXNB2 is therefore required for the physiological and pathological functions of ANG and has significant therapeutic potential in solid and hematopoietic cancers and neurodegenerative diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom